COVID-19 and Clinical Trials: The Ripple Effect

The pandemic will have a far-reaching impact on clinical trials, which will ripple out to all areas of our industry. Are you ready?

COVID-19 CLINICAL HEOR/REAL-WORLD EVIDENCE POLICY/ACCESS MARKETING COMMUNICATIONS ADVOCACY MEDICAL AFFAIRS PUBLICATIONS

Resources

The AVENIR GLOBAL family of specialist healthcare communications agencies have combined our deep experience and expertise to craft a curated selection of resources that can help you successfully navigate through these uncertain times.

Clinical

Looking for tips for supporting investigators, site staff or study participants, particularly during this challenging time? We can help.

Medical Affairs

Assessing how to continue ensuring scientific exchange and provide valuable education for healthcare providers? We have some suggestions.

Publications

Wondering what is the best approach for your congress and publication strategies as data opportunities continue to evolve? Our insights might help.

Communications

Re-evaluating your internal and external comms activities to adapt to the continuously shifting situation? We have some thought-starters.

Advocacy

Considering how the current emphasis on COVID-19 will affect your advocacy partners in other areas? We can help.

Marketing

Looking ahead to how your launch plans may be affected by clinical trial delays? We are here to support you.

Policy/Access

Contemplating how the pandemic may change the regulatory landscape? Our perspectives may help.

HEOR/Real-World Evidence

Thinking about the role real-world evidence can play in this new era for clinical trials? We have some ideas.

Get in Touch

We know there are numerous considerations when it comes to the impact of COVID-19 on clinical trials and what this means for your organization. We are here to help.